FREQUENCY OF MATERNAL SEPSIS AMONG GRAVID FEMALES WHO HAD VAGINAL DELIVERY TREATED WITH PROPHYLACTIC AZITHROMYCIN

Background: Maternal sepsis is a significant contributor to maternal morbidity and mortality globally, accounting for nearly 10% of maternal deaths. The use of prophylactic antibiotics during childbirth has shown promise in reducing infection-related complications. Azithromycin, a broad-spectrum macrolide, has demonstrated efficacy in reducing maternal infections in previous studies. This study evaluates the frequency of maternal sepsis among gravid females who underwent vaginal delivery and were treated with a prophylactic dose of azithromycin. Objective: To determine the frequency of maternal sepsis among gravid females who had vaginal delivery and were treated with a single prophylactic dose of oral azithromycin. Methods: This descriptive case series was conducted over six months in the Department of Obstetrics and Gynecology at Jinnah Hospital, Lahore. A total of 140 gravid females, aged 18–40 years, were enrolled using non-probability consecutive sampling. Patients received a single oral dose of 2g azithromycin within six hours of vaginal delivery. They were observed for 24 hours post-delivery, discharged if asymptomatic, and monitored via phone for six days. Maternal sepsis was defined based on clinical symptoms, vital signs, and blood culture results. Data were analyzed using SPSS version 25. Results: Among 140 participants, 27 women (19.2%) developed maternal sepsis. Of these, 22 (15.7%) had a low-grade fever (99°F), while 5 (3.6%) experienced high-grade fever (≥101°F). The highest recorded temperature was 103°F. The remaining 113 patients (80.7%) remained asymptomatic, reporting no fever or other signs of infection. All patients tolerated azithromycin without adverse effects. Conclusion: Prophylactic administration of oral azithromycin within six hours of vaginal delivery significantly reduces the risk of maternal sepsis. This intervention is well-tolerated and holds promise for improving maternal outcomes, particularly in settings with limited resources.

Authors

Institutions

Publication Details

Journal
Insights-Journal of Health and Rehabilitation
Published
2024-12-04
DOI
https://doi.org/10.71000/ijhr165
Primary Topic
Preterm Birth and Chorioamnionitis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FREQUENCY OF MATERNAL SEPSIS AMONG GRAVID FEMALES WHO HAD VAGINAL DELIVERY TREATED WITH PROPHYLACTIC AZITHROMYCIN

Kabir A. Khan, Noor Ul Huda, Aqsa Tassadduq, Alveena Khan et al.
Insights-Journal of Health and Rehabilitation
Preterm Birth and Chorioamnionitis
article

FREQUENCY OF MATERNAL SEPSIS AMONG GRAVID FEMALES WHO HAD VAGINAL DELIVERY TREATED WITH PROPHYLACTIC AZITHROMYCIN

Kabir A. Khan, Noor Ul Huda, Aqsa Tassadduq, Alveena Khan, Maria Ahmed, Nimra Sajid
article en

Abstract

Background: Maternal sepsis is a significant contributor to maternal morbidity and mortality globally, accounting for nearly 10% of maternal deaths. The use of prophylactic antibiotics during childbirth has shown promise in reducing infection-related complications. Azithromycin, a broad-spectrum macrolide, has demonstrated efficacy in reducing maternal infections in previous studies. This study evaluates the frequency of maternal sepsis among gravid females who underwent vaginal delivery and were treated with a prophylactic dose of azithromycin. Objective: To determine the frequency of maternal sepsis among gravid females who had vaginal delivery and were treated with a single prophylactic dose of oral azithromycin. Methods: This descriptive case series was conducted over six months in the Department of Obstetrics and Gynecology at Jinnah Hospital, Lahore. A total of 140 gravid females, aged 18–40 years, were enrolled using non-probability consecutive sampling. Patients received a single oral dose of 2g azithromycin within six hours of vaginal delivery. They were observed for 24 hours post-delivery, discharged if asymptomatic, and monitored via phone for six days. Maternal sepsis was defined based on clinical symptoms, vital signs, and blood culture results. Data were analyzed using SPSS version 25. Results: Among 140 participants, 27 women (19.2%) developed maternal sepsis. Of these, 22 (15.7%) had a low-grade fever (99°F), while 5 (3.6%) experienced high-grade fever (≥101°F). The highest recorded temperature was 103°F. The remaining 113 patients (80.7%) remained asymptomatic, reporting no fever or other signs of infection. All patients tolerated azithromycin without adverse effects. Conclusion: Prophylactic administration of oral azithromycin within six hours of vaginal delivery significantly reduces the risk of maternal sepsis. This intervention is well-tolerated and holds promise for improving maternal outcomes, particularly in settings with limited resources.

Insights-Journal of Health and RehabilitationVol. 2(2 (Health & Rehab))
Jinnah Postgraduate Medical Center (PK), Benazir Bhutto Hospital (PK), University of Health Sciences Lahore (PK), Divisional Headquarters Teaching Hospital Mirpur (PK), Mirpur University of Science and Technology (PK)
Openalex Percentile: Top 64%
Preterm Birth and Chorioamnionitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.